Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹17 Cr
Revenue (TTM)
₹25 Cr
Net Profit (TTM)
₹-1 Cr
ROE
-9.5 %
ROCE
-4.5 %
P/E Ratio
--
P/B Ratio
1.4
Industry P/E
39.8
EV/EBITDA
72.4
Div. Yield
0 %
Debt to Equity
0
Book Value
₹28.5
EPS
₹-2.3
Face value
10
Shares outstanding
4,440,568
CFO
₹13.40 Cr
EBITDA
₹16.30 Cr
Net Profit
₹3.62 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Link Pharma Chem
| -5.4 | 11.7 | 11.0 | -12.2 | -1.1 | 23.8 | 14.8 |
|
BSE Commodities
| 5.1 | -1.4 | 6.1 | -1.4 | 18.4 | 25.9 | -- |
|
BSE Small Cap
| -4.9 | 2.1 | 15.7 | 0.8 | 29.2 | 33.9 | 16.9 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|---|---|---|---|---|---|---|---|
|
Link Pharma Chem
| -9.5 | -18.5 | 0.5 | 133.2 | 78.3 | -53.9 | 5.7 |
|
BSE Small Cap
| 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 | -23.4 |
|
BSE Commodities
| 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 | -19.2 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Link Pharma Chem
|
38.7 | 17.2 | 25.4 | -1.0 | -3.2 | -7.8 | -- | 1.4 |
| 1,964.6 | 10,052.7 | 1,571.8 | 186.1 | 14.0 | 14 | 54 | 7.2 | |
| 1,715.3 | 7,396.8 | 2,550.1 | 357.7 | 22.7 | 22.6 | 20.7 | 3.9 | |
| 2,495.1 | 8,848.4 | 4,223.7 | 304.9 | 8.9 | 13.2 | 29 | 3.7 | |
| 589.7 | 5,660.6 | 3,183.5 | 624.2 | 24.0 | 18.7 | 9.1 | 1.6 | |
| 573.1 | 4,193.6 | 4,072.9 | 15.8 | -0.8 | -1.1 | -- | 0.7 | |
| 2,854.8 | 9,161.2 | 14,828.2 | 1,254.4 | 13.6 | 8.9 | 14.5 | 1.3 | |
| 3,050.9 | 3,697.3 | 1,744.7 | 152.9 | 11.7 | 22.1 | 24.2 | 5.1 | |
| 900.8 | 2,107.0 | 382.7 | 5.7 | 1.7 | 0.8 | 368.8 | 2.9 | |
| 538.5 | 3,619.9 | 1,446.6 | 126.6 | 13.1 | 15 | 28.6 | 3.9 |
No Review & Analysis are available.
Link Pharma Chem Limited manufactures and sells organic intermediates for pharmaceutical, agro, and specialty chemicals industries in India and internationally. It also engages in the custom synthesis/contract manufacturing for multistage synthesis... for small, medium, and large companies. The company also exports its products. The company was incorporated in 1984 and is based in Vadodara, India. Read more
Incorporated
1984
Chairman
Satish Kumar Thakur
Managing Director
Rishikesh Thakur
Headquarters
Vadodara Dist, Gujarat
Website
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The total asset value of Link Pharma Chem Ltd stood at ₹ 23 Cr as on 31-Mar-25
The share price of Link Pharma Chem Ltd is ₹38.65 (BSE) as of 19-Jun-2025 IST. Link Pharma Chem Ltd has given a return of -1.14% in the last 3 years.
Link Pharma Chem Ltd has a market capitalisation of ₹ 17 Cr as on 19-Jun-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Link Pharma Chem Ltd is 1.36 times as on 19-Jun-2025, a 26% discount to its peers’ median range of 1.83 times.
Since, TTM earnings of Link Pharma Chem Ltd is negative, P/E ratio is not available.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Link Pharma Chem Ltd and enter the required number of quantities and click on buy to purchase the shares of Link Pharma Chem Ltd.
Link Pharma Chem Limited manufactures and sells organic intermediates for pharmaceutical, agro, and specialty chemicals industries in India and internationally. It also engages in the custom synthesis/contract manufacturing for multistage synthesis for small, medium, and large companies. The company also exports its products. The company was incorporated in 1984 and is based in Vadodara, India.
The prominent promoters of Link Pharma Chem Ltd. are
| Name of promoters | Holding percentage |
|---|---|
|
Rishikesh Satishbhai Thakur |
18.95%
|
|
Maya Satish Thakur |
15.55%
|
|
Satish Ganpatrao Thakur |
14.91%
|
|
Shriniwas Vasantrao Thakur |
2.09%
|
The chairman of the company is Satish Kumar Thakur, and the managing director is Rishikesh Thakur.
There is no promoter pledging in Link Pharma Chem Ltd.
Some of the close peers are:
| Company | Market Cap(₹ Cr) |
|---|---|
|
10,177
|
|
|
8,811
|
|
|
8,414
|
|
|
7,846
|
|
|
6,036
|
|
|
4,316
|
|
|
3,768
|
|
|
3,714
|
|
|
2,209
|
| Link Pharma Chem Ltd. | Ratios |
|---|---|
|
Return on equity(%)
|
-7.77
|
|
Operating margin(%)
|
-3.2
|
|
Net Margin(%)
|
-4
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Link Pharma Chem Ltd was ₹-1 Cr.
₹2.65
(
